Quantcast
Last updated on April 18, 2014 at 15:19 EDT

BioRestorative Therapies, Inc. Announces Launch of New Stem Pearls® Website and E-Commerce Platform for Skincare Product Line

July 16, 2012

JUPITER, Fla., July 16, 2012 /PRNewswire/ – BioRestorative Therapies, Inc. (“BRT”) (OTCQB: BRTX) announced today that its Stem Pearls® subsidiary has launched its new website, enabling its products to be purchased on the company’s website at www.stempearls.com or by calling (855) 77-PEARL.

Formulated around an award winning ingredient, the Stem Pearls® product line uses plant stem cells known for their regenerative and anti-aging properties. The star product, Apple Stem Cell Serum, along with other complementary beauty care products (Apple Amber Scrub, Apple Glycolic Cleanser and Moisturizing Treatment), are designed to provide a full skincare regimen.

The brand offers a carefully prepared product set designed to cleanse, exfoliate, treat, and moisturize facial skin in a modern way using plant stem cells as the primary ingredient to address anti-aging. The four product set retails for $300. Products can also be purchased individually, and more information (including product benefits) can be found on the website.

Mark Weinreb, Chief Executive Officer of BRT, stated, “We are excited to begin our much anticipated e-commerce campaign for our Stem Pearls® product line. This beauty regimen is a fantastic way for consumers to restore their youthful attributes through scientifically formulated products. Testimonials by those who have used the product have been overwhelmingly positive. In response to requests for us to expand our product line, we are considering other anti-aging products.”

About BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc.’s (“BRT”) goal is to become a leader in developing medical procedures using cell and tissue protocols, primarily involving adult stem cells (non-embryonic), and allowing patients to undergo minimally invasive cellular-based treatments. BRT is developing the following scientific initiatives: Our brtxDISC(TM) Program (Disc Implanted Stem Cells) offers a non-surgical treatment for bulging and herniated discs and addresses the gap between non-invasive and invasive back procedures. Our ThermoStem(TM) Program focuses on treatments for metabolic disorders (diabetes, heart disease, etc.) and obesity and uses brown fat stem cells, which initial research indicates increased caloric burning and reduced glucose and lipid levels in the body. The Company also offers plant stem cell-based facial creams and products under the Stem Pearls® brand at www.stempearls.com.

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including those set forth in the Company’s Form 10-K filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.

Investor Contacts:
KCSA Strategic Communications
Philip Carlson / Josh Dver
+1 212.896.1233 / +1 212.896.1239
pcarlson@kcsa.com / jdver@kcsa.com

SOURCE BioRestorative Therapies, Inc.


Source: PR Newswire